Welcome to our Lab Website
Explore our website to learn more about the research we are doing to understand cerebellar diseases, including Spinocerebellar Ataxia Type 6 (SCA6).
Christopher M. Gomez MD PhD has worked in the field of ataxia for more than 25 years. Dr. Gomez’s long term goals are to help characterize the pathogenic mechanisms that cause ataxia, develop treatments, and to identify disease and stage-specific biomarkers of ataxia. Dr. Gomez is an expert in neurogenetic disorders, gait and balance disorders, and in the diagnosis and treatment of patients with ataxias — a family of rare neurodegenerative diseases. Dr. Gomez’s laboratory research concentrates on the molecular and cellular mechanisms of neurodegenerative disease–with a focus on the means by which genetic mutations in ion channels or other essential proteins lead to dominantly inherited neurodegenerative diseases. His research has resulted in more than 100 peer-reviewed publications in scientific journals.